Onyeka Chukwudozie is an Immunopaedia Ambassador from Nigeria. He is currently pursuing a Ph.D. at the University of California, San Diego, working in Erica Ollmann Saphire’s Lab at the La Jolla Institute for Immunology. Onyeka attended IUIS-FAIS Immuno-Ethiopia a course in 2020. His research involves the fields of immunology, virology, and structural biology to develop long-lasting neutralizing antibodies that are cross-reactive against multiple lineages of Lassa virus.
He focuses on characterizing the human B cell response to LASV vaccination using novel, conformation-specific antigens, which could lead to the establishment of effective Lassa virus vaccines. Onyeka aims to contribute to the global fight against viral pandemics and improve the health outcomes of vulnerable populations worldwide.
Recent Publications:
- A cocktail of protective antibodies subverts the dense glycan shield of Lassa virus https://www.science.org/doi/abs/10.1126/scitranslmed.abq0991
- Discovery of putative inhibitors against main drivers of SARS-CoV-2 infection: Insight from quantum mechanical evaluation and molecular modeling. https://www.scienceopen.com/document_file/251f17e6-15bd-4709-88b2-53f026e9554b/PubMedCentral/251f17e6-15bd-4709-88b2-53f026e9554b.pdf
- Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0248061
You can get in touch with me by:
LinkedIn – Onyeka S. Chukwudozie
ResearchGate – Onyeka Chukwudozie
